Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Close this folderAppendix: Electronic sources of information
View the documentFor general access to evidence
View the documentJournal articles
View the documentSystematic reviews
View the documentNational disease prevention and control, health promotion etc.
View the documentHealth technology assessment
View the documentClinical guidelines
View the documentFormularies/Essential medicines
View the documentRegulatory authorities
View the documentAdverse effects
View the documentInformation about/for patients
View the documentDrug promotion
View the documentNetworks and directories
View the documentISDB member bulletins
View the documentFeedback and evaluation form

Networks and directories


An e-mail discussion forum on essential drugs, national drug policies and standard treatment guidelines. It is also a good source of information on future conferences and courses, new publications, recent articles, and broader political (e.g. trade, patents, pricing) aspects of medicines access. More information:

In Spanish: Acerca de E-FARMACOS

INASP-Health Directory

International Network for the Availability of Scientific Publications
A directory of international organizations and programmes working to improve access to reliable information for health professionals. Links to providers of free or low-cost information.


This is a joint venture between WHO and the Health Information Forum (HIF), providing a neutral focal point for finding out about useful sources of information and also for discussion of issues relating to access and use of information by health professionals in developing countries. The email list brings together the full range of stakeholders involved in the creation, provision and use of healthcare information, from over 130 countries worldwide.


An electronic discussion group for English-speaking colleagues working in the area of non-essential drug information and drug information centres. It provides a forum for discussion of issues around the organization of drug information centres including set-up, funding, management, quality and training. It also supports the promotion of objective drug information, answers technical questions on drugs that cannot be solved by standard textbooks, and responds to queries on non-essential drugs.

INASP Health Links

The Internet Gateway to selected web sites for health professionals, medical librarians, and publishers in developing and transitional countries.

Includes section on pharmacology and prescribing:


to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017